Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
- Postato il 2 aprile 2026
- Di CNBC
- 11 Visualizzazioni
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
